Register Now - Every Drop Matters: Reducing Product Loss in Sterile Filtration
|Articles|January 27, 2015

FUJIFILM Diosynth Begins Work on Bioprocess Innovation Center

The new facility will feature new research and development capabilities.


FUJIFILM Diosynth announced on Jan. 13, 2015 that the company is opening a new facility in Research Triangle Park, North Carolina. The new location, called the Bioprocess Innovation Center, will offers clients services in process invention and process and product characterization for its clients, according to a press release.

"The construction of this building reflects the continued commitment of our organization to provide our clients with the infrastructure to efficiently and innovatively bring their products to the clinic and beyond for the benefit of their patients," said Steve Bagshaw, CEO, FUJIFILM Diosynth Biotechnologies.

The three-story, 62,000-square-foot facility has an expected completion date in the fourth quarter of 2015.

Source:
FUJIFILM


Related to this article

The BioPharm Brief: Long-Term Survival Data for a PD-L1/4-1BB Bispecific, Celldex Exits Atopic Dermatitis, and a Fc-Fusion GLP-1 Goes Global
Leads Biolabs details survival data and 2027 ADC combination plans for its PD-L1/4-1BB bispecific opamtistomig, Celldex Therapeutics ends its atopic dermatitis program for anti-KIT antibody barzolvolimab after a phase 2 miss, and Innogen licenses its Fc-fusion GLP-1 receptor agonist efsubaglutide alfa to Arcera Life Sciences for international markets.